Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Prelude Therapeutics Inc changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 55 | +8 |
| Shares | 28.5M | 1.41M | 30.8M | +3.71M (+13.7%) |
| Value | $82.6M | $4.10M | $105.2M | +$26.8M (+34.1%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Prelude Therapeutics Inc at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 1,230,406 | $4.21M | 0.00% |
| EcoR1 Capital, LLC | 947,049 | $3.24M | 0.14% |
| Vanguard Fiduciary Trust Co | 157,380 | $538.2K | 0.00% |
| ADAR1 Capital Management, LLC | 152,825 | $522.7K | 0.03% |
| Citadel Advisors LLC | 124,378 | $425.4K | 0.00% |
| HRT Financial LP | 58,699 | $200.0K | 0.00% |
| Dimensional Fund Advisors LP | 35,210 | $119.7K | 0.00% |
| Diametric Capital, LP | 11,980 | $41.0K | 0.01% |
| Nine Masts Capital Ltd | 11,699 | $40.0K | 0.01% |
| Graham Capital Management, L.P. | 11,343 | $38.8K | 0.00% |
| American Century Companies Inc | 10,294 | $35.2K | 0.00% |
| Vanguard Global Advisers, LLC | 4,636 | $15.9K | 0.00% |
| Fortitude Family Office, LLC | 230 | $787 | 0.00% |
Sold out (5)
Institutions that held Prelude Therapeutics Inc at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Price T Rowe Associates Inc | 755,956 | $2.19M |
| Two Sigma Advisers, LP | 237,300 | $688.2K |
| TD Asset Management Inc | 160,652 | $465.9K |
| Manufacturers Life Insurance Company, The | 70,546 | $200.4K |
| IFP Advisors, Inc | 1 | $3 |
Not filed for Q1 2026 yet (1)
Institutions that held Prelude Therapeutics Inc at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,413,986 | $4.10M |